REDMOND,
Wash., July 26, 2024 /PRNewswire/ -- The Centers
for Medicare & Medicaid Services (CMS), in its 2025 Physician
Fee Schedule (PFS) Proposed Rule, announced its intent to create
three new supply codes in its direct Practice Expense (PE) Database
to describe the inFlow Voiding Prosthesis and facilitate
appropriate payment rates for related physician services. Vesiflo
appreciates CMS' acknowledgment of inconsistencies in pricing for
the relevant physician service codes by the Medicare Administrative
Contractors (MACs) to whom decisions about payment and coverage
have been delegated by CMS. Per CMS, the creation of the new supply
codes should help the MACs to establish more consistency and
appropriate inclusion of the inFlow in pricing for these
services.
Kevin Connolly, CEO of Vesiflo,
applauds CMS' proposal, stating, "The inFlow voiding
prosthesis is the only alternative to life-long use of urinary
catheters for women with impaired bladder function due to
life-altering neurologic conditions like MS, spinal cord injury,
spina bifida and multiple system atrophy. It is frustrating for
prescribing physicians to be responsible for purchasing supplies to
treat these patients and then have to repeatedly challenge the MACs
for appropriate payment. We are grateful to CMS for acknowledging
the challenges that inconsistent and uncertain payment creates for
patient access and for proposing to create new supply codes to
facilitate the setting of consistent and appropriate payment rates
that account for the device costs."
The supply codes that CMS proposes to create describe the inFlow
Measuring Device (SD370) with a proposed price of $140, the inFlow Valve-Pump (SD371) with a
proposed price of $495, and the
inFlow Activator Kit (SD372) with a proposed price of $1,250. If finalized, these codes would take
effect on Jan. 1, 2025, at which
time Vesiflo plans to initiate national sales.
Jerry Stringham, President of the
reimbursement consulting firm Medical Technology Partners, added,
"While some of the MACs have established appropriate payment,
others have continued to underpay for inflow-related services. We
welcome and fully support CMS' statement in the 2025 proposed
rule that the MACs should establish appropriate payment for inFlow
and that the payment rate needs to incorporate the components of
the inFlow system. This will simplify the process of establishing
appropriate and consistent fee schedules for each of the MACs."
Comments on the proposed rule are open until Sept. 9, 2024.
Vesiflo is the manufacturer of the
inFlow™ voiding prosthesis used by women with
permanent urinary retention. For more information, go to
www.vesiflo.com.
Please contact: Susan Robinson,
380909@email4pr.com
Contact:
Susan Robinson
380909@email4pr.com
425-242-6373
View original content to download
multimedia:https://www.prnewswire.com/news-releases/vesiflo-applauds-cms-proposal-to-create-supply-codes-for-the-inflow-voiding-prosthesis-to-facilitate-appropriate-physician-payment-rates-302207002.html
SOURCE Vesiflo